NEW YORK (GenomeWeb) – Biocept has entered into a $10 million loan and security agreement with Oxford Finance, the San Diego-based oncology diagnostics firm said in a US Securities and Exchange document on Tuesday.

Biocept received a $5 million loan on April 30 and will receive another $5 million loan prior to Dec. 31, 2015, subject to the firm achieving at least $9 million in product and service revenues for a six-month period ending no later than Nov. 30, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.